Skip to main content
. 2019 Dec 9;14(2):207–221. doi: 10.1007/s12079-019-00539-1

Fig. 8.

Fig. 8

A putative model for therapeutic targets of lutein on hyperglycemia-mediated oxidative damage in ARPE-19. Lutein activates Nrf2 translocation through activating its upstream regulators, PI3K-AKT and Erk1/2, and thereby upregulates protective antioxidant enzymes in hyperglycemic ARPE-19 cells